🇺🇸 FDA
Patent

US 9808458

Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria

granted A61KA61K31/42A61K31/422

Quick answer

US patent 9808458 (Plasmodial surface anion channel inhibitors for the treatment or prevention of malaria) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Nov 07 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Nov 02 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/42, A61K31/422, A61K31/423, A61K31/427